Drug Discovery and Development: Technology In Transition
ISBN-13:
9780443064203
ISBN-10:
0443064202
Edition:
1
Author:
Humphrey P. Rang MB BS MA DPhil Hon FBPharmacolS FMedSci FRS
Publication date:
2006
Publisher:
Churchill Livingstone
Format:
Paperback
360 pages
Category:
Pharmacy
,
Pharmacology
FREE US shipping
Book details
ISBN-13:
9780443064203
ISBN-10:
0443064202
Edition:
1
Author:
Humphrey P. Rang MB BS MA DPhil Hon FBPharmacolS FMedSci FRS
Publication date:
2006
Publisher:
Churchill Livingstone
Format:
Paperback
360 pages
Category:
Pharmacy
,
Pharmacology
Summary
Drug Discovery and Development: Technology In Transition (ISBN-13: 9780443064203 and ISBN-10: 0443064202), written by authors
Humphrey P. Rang MB BS MA DPhil Hon FBPharmacolS FMedSci FRS, was published by Churchill Livingstone in 2006.
With an overall rating of 3.8 stars, it's a notable title among other
Pharmacy
(Pharmacology) books. You can easily purchase or rent Drug Discovery and Development: Technology In Transition (Paperback) from BooksRun,
along with many other new and used
Pharmacy
books
and textbooks.
And, if you're looking to sell your copy, our current buyback offer is $0.3.
Description
This title is directed primarily toward health care professionals outside the United States. An ideal introduction to the pharmaceutical industry, this book describes the process of bringing a new drug to the marketplace. It explains why, although thousands of compounds show initial promise, only a small handful will be developed for human clinical trials and perhaps only one will become an approved drug. Describing the huge complexities involved, it shows how new molecular understanding and techniques can make the process more targeted and successful.
- Includes the new molecular techniques of drug design and development.
- Discusses current therapeutic needs.
- Covers pharmacoepidemiology and pharmacoeconomics.
- Edited by Humphrey Rang, who is also known throughout the world as a co-author of the enormously successful and authoritative textbook, Pharmacology, now in its fifth edition.
- Foreword by Daniel Vasella, CEO, Novartis International.
- Includes contributors from both the pharmaceutical industry and universities.
We would LOVE it if you could help us and other readers by reviewing the book
Book review
Congratulations! We have received your book review.
{user}
{createdAt}
by {truncated_author}